NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 262 filers reported holding NOVOCURE LTD in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,672,025 | +893.1% | 846,565 | +2451.9% | 0.04% | +1133.3% |
| Q2 2023 | $1,376,721 | +11.1% | 33,174 | +61.0% | 0.00% | -25.0% |
| Q1 2023 | $1,238,884 | +463.0% | 20,600 | +586.7% | 0.00% | +300.0% |
| Q4 2022 | $220,050 | -94.1% | 3,000 | -93.9% | 0.00% | -92.3% |
| Q3 2022 | $3,741,000 | -68.6% | 49,239 | -71.3% | 0.01% | -66.7% |
| Q2 2022 | $11,924,000 | +37.0% | 171,567 | +63.3% | 0.04% | +50.0% |
| Q1 2022 | $8,703,000 | -70.9% | 105,048 | -73.6% | 0.03% | -59.4% |
| Q4 2021 | $29,865,000 | -19.1% | 397,787 | +25.1% | 0.06% | -22.0% |
| Q3 2021 | $36,926,000 | +167.9% | 317,856 | +411.5% | 0.08% | +164.5% |
| Q2 2021 | $13,785,000 | -74.4% | 62,146 | -84.7% | 0.03% | -77.9% |
| Q1 2021 | $53,750,000 | +492.2% | 406,643 | +675.3% | 0.14% | +438.5% |
| Q4 2020 | $9,077,000 | +2617.7% | 52,452 | +1648.4% | 0.03% | +2500.0% |
| Q3 2020 | $334,000 | -98.4% | 3,000 | -99.1% | 0.00% | -99.0% |
| Q2 2020 | $20,603,000 | +171.7% | 347,440 | +208.5% | 0.10% | +64.5% |
| Q1 2020 | $7,583,000 | -71.6% | 112,612 | -64.4% | 0.06% | -23.5% |
| Q4 2019 | $26,661,000 | -48.9% | 316,376 | -54.6% | 0.08% | -54.0% |
| Q3 2019 | $52,166,000 | +35.7% | 697,591 | +14.7% | 0.18% | +36.4% |
| Q2 2019 | $38,454,000 | +34.7% | 608,173 | +2.6% | 0.13% | +38.7% |
| Q1 2019 | $28,547,000 | +590.0% | 592,623 | +379.6% | 0.09% | +481.2% |
| Q4 2018 | $4,137,000 | -89.2% | 123,576 | -83.1% | 0.02% | -84.8% |
| Q3 2018 | $38,368,000 | +161.3% | 732,207 | +56.1% | 0.10% | +138.6% |
| Q2 2018 | $14,685,000 | +3421.6% | 469,181 | +2351.4% | 0.04% | +4300.0% |
| Q1 2018 | $417,000 | -79.2% | 19,139 | -80.7% | 0.00% | -85.7% |
| Q4 2017 | $2,002,000 | +213.3% | 99,106 | +247.0% | 0.01% | +133.3% |
| Q4 2015 | $639,000 | – | 28,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |